Opko Health Inc (OPK) : Fridays money flow points at investors jumping to buy the stock on the weakness of price. $1.33 million worth of transactions were on upticks, whereas, the downticks accounted for $0.92 million worth of transactions. The net money flow was a positive $0.41 million and the uptick to downtick ratio was 1.44. The net money flow into the stock was $0.17 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $0.17 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. Opko Health Inc (OPK) was trading at $9.27, down $0.02 during day. The stock slid -0.22% over the previous days close. For the week, the stock recorded 1.64% over the previous weeks close.
The company Insiders own 40.74% of Opko Health Inc shares according to the proxy statements. Institutional Investors own 20.51% of Opko Health Inc shares. During last six month period, the net percent change held by insiders has seen a change of -0.63%.
In a related news, Frost Gamma Investments Trust, CEO of Opko Health, Inc. had purchased 48,400 shares on August 25, 2016 in a transaction. The price per share was $9.07 and the total amount of the disclosed transaction was $438,988.The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. This information is based on open market transaction at the market prices.
Opko Health Inc (NYSE:OPK): The stock opened at $9.34 and touched an intraday high of $9.39 on Friday. During the day, the stock corrected to an intraday low of $9.16, however, the bulls stepped in and pushed the price higher to close in the green at $9.33 with a gain of 0.43% for the day. The total traded volume for the day was 2,061,175. The stock had closed at $9.29 in the previous trading session.
Opko Health Inc (OPK) has been under a strong bear grip, hence the stock is down -7.59% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 1.79% in the past 1 week. The stock has risen by 2.3% in the past week indicating that the buyers are active at lower levels, but the stock is down -7.72% in the past 4 weeks.
OPKO Health, Inc. (OPKO) is a biopharmaceutical and diagnostics company. The Company is involved in developing a range of solutions to diagnose, treat and prevent various conditions, including point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and pharmaceuticals and vaccines. It operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment consists of two operating segments pharmaceutical research and development segment and pharmaceutical operations. Its diagnostics segment consists of pathology operations and point-of-care and molecular diagnostics operations. It owns pharmaceutical operations in Chile, Spain, Mexico, Israel, Uruguay and Brazil. The product pipeline includes several pharmaceutical compounds and technologies in research and development for a range of indications and conditions.